- Home
- UPWK vs IMCR Comparison
UPWK vs IMCR Comparison
Compare UPWK & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPWK
- IMCR
- Stock Information
- Founded
- UPWK 2013
- IMCR 2008
- Country
- UPWK United States
- IMCR United Kingdom
- Employees
- UPWK N/A
- IMCR N/A
- Industry
- UPWK EDP Services
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UPWK Technology
- IMCR Health Care
- Exchange
- UPWK Nasdaq
- IMCR Nasdaq
- Market Cap
- UPWK 1.8B
- IMCR 1.7B
- IPO Year
- UPWK 2018
- IMCR 2021
- Fundamental
- Price
- UPWK $14.91
- IMCR $32.03
- Analyst Decision
- UPWK Strong Buy
- IMCR Buy
- Analyst Count
- UPWK 11
- IMCR 13
- Target Price
- UPWK $17.00
- IMCR $68.73
- AVG Volume (30 Days)
- UPWK 3.4M
- IMCR 238.6K
- Earning Date
- UPWK 11-06-2024
- IMCR 11-06-2024
- Dividend Yield
- UPWK N/A
- IMCR N/A
- EPS Growth
- UPWK N/A
- IMCR N/A
- EPS
- UPWK 0.62
- IMCR N/A
- Revenue
- UPWK $761,776,000.00
- IMCR $296,312,000.00
- Revenue This Year
- UPWK $11.96
- IMCR $28.88
- Revenue Next Year
- UPWK $3.59
- IMCR $12.61
- P/E Ratio
- UPWK $24.01
- IMCR N/A
- Revenue Growth
- UPWK 14.27
- IMCR 25.09
- 52 Week Low
- UPWK $8.43
- IMCR $29.72
- 52 Week High
- UPWK $17.79
- IMCR $76.98
- Technical
- Relative Strength Index (RSI)
- UPWK 64.74
- IMCR 56.41
- Support Level
- UPWK $15.52
- IMCR $32.65
- Resistance Level
- UPWK $16.37
- IMCR $34.78
- Average True Range (ATR)
- UPWK 0.69
- IMCR 1.54
- MACD
- UPWK 0.02
- IMCR 0.21
- Stochastic Oscillator
- UPWK 45.35
- IMCR 74.74
About UPWK Upwork Inc.
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to clients.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.